Funder: European Commission
Due Dates: May 22, 2025 (Opening) | September 16, 2025 (Deadline)
Funding Amounts: €4,000,000 to €8,000,000 per project | Up to 10 projects funded | Max duration: 4 years
Summary: Supports consortia to accelerate early clinical development of innovative biotech therapies, with a strong focus on EU SMEs and market deployment.
Key Information: At least 50% of the EU contribution must go to SMEs; consortia can include up to 5 beneficiaries only.